MedPath

A randomized clinical trial comparing intracorpus spongiosumblock versus intraurethral lignocaine in visual internalurethrotomy for short segment anterior urethral strictures

Not Applicable
Completed
Conditions
Health Condition 1: N35- Urethral stricture
Registration Number
CTRI/2017/11/010503
Lead Sponsor
Department of Urology Institute of PostGraduate Medical Education and Research and SSKM Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

Male patients 18 years or above.

-Single anterior urethral stricture up to 2 cm of length.

Exclusion Criteria

-Multiple strictures.

-Stricture of fossa navicularis.

-Stricture length more then 2 cm.

-Known allergy to lignocaine.

-Associated urological co-morbidities like urethral or vesical calculus, benign prostatic hyperplasia, neurovesical dysfunction.

-Significant cardiovascular disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain perception with the help of Visual Analogue Scale.Timepoint: 1.Pain during the surgery (VIU) <br/ ><br>2.One hour after the of surgery completed.
Secondary Outcome Measures
NameTimeMethod
Change of Systolic BP & Pulse rate during the surgery and 1 hour after surgery from baseline (pre-operative) value.Timepoint: 1.Maximum value during intraoperative period. <br/ ><br>2.At 1 hour post operative period.;Success of VIU will be measured at 6 months after the surgery (The procedure will be considered successful if the patient do not report any voiding difficulty and urethral calibration is easy with an 18F Foley catheter).Timepoint: 6 months post surgery.
© Copyright 2025. All Rights Reserved by MedPath